Novartis and Voyager Therapeutics reach licence option agreement for next-generation gene therapy vectors for neurological diseases Read more
Novartis and Molecular Partners report positive topline data from phase-II study for Ensovibep Read more
Schneider Electric launches programme to increase access to renewable energy for pharmaceutical suppliers Read more
Novartis to manufacture anti-cholesterol drug Leqvio for US in Austria due to delay in US clearance Read more
Novartis, Cadila Healthcare lead digital marketing space for ankylosing spondylitis in India: GlobalData Read more